Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Common Stock | Options Exercise | $0 | +1.22K | +3.38% | $0.00 | 37.4K | Feb 28, 2022 | Direct | F1 |
transaction | BSX | Common Stock | Tax liability | -$16.5K | -374 | -1% | $44.17 | 37K | Feb 28, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -1.22K | -100% | $0.00* | 0 | Feb 28, 2022 | Common Stock | 1.22K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F2 | Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |